Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.8 USD | -6.96% | +1.50% | +5.99% |
15/05 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
14/05 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.99% | 51Cr | |
+44.48% | 5.4TCr | |
+43.57% | 4.2TCr | |
-0.86% | 4.19TCr | |
-7.59% | 2.84TCr | |
+12.30% | 2.64TCr | |
-21.83% | 1.9TCr | |
+7.15% | 1.3TCr | |
+29.40% | 1.23TCr | |
+25.15% | 1.22TCr |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Baird Adjusts Frequency Therapeutics Price Target to $4 From $10, Maintains Outperform Rating